0000874015-15-000061.txt : 20150702
0000874015-15-000061.hdr.sgml : 20150702
20150702175758
ACCESSION NUMBER: 0000874015-15-000061
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150701
FILED AS OF DATE: 20150702
DATE AS OF CHANGE: 20150702
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000874015
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330336973
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
BUSINESS PHONE: 7609319200
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Castleman Breaux
CENTRAL INDEX KEY: 0001335073
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19125
FILM NUMBER: 15971327
MAIL ADDRESS:
STREET 1: 7 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-07-01
0000874015
ISIS PHARMACEUTICALS INC
ISIS
0001335073
Castleman Breaux
C/O ISIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT
CARLSBAD
CA
92010
1
0
0
0
Common Stock
2015-07-01
2015-07-01
4
M
0
938
0
A
2345
D
Common Stock
2015-07-01
2015-07-01
4
M
0
469
0
A
2814
D
Common Stock
2015-07-01
2015-07-01
4
M
0
667
0
A
3481
D
Restricted Stock Units
2015-07-01
2015-07-01
4
M
0
938
0
D
Common Stock
938
1874
D
Restricted Stock Units
2015-07-01
2015-07-01
4
M
0
469
0
D
Common Stock
469
937
D
Restricted Stock Units
2015-07-01
2015-07-01
4
M
0
667
0
D
Common Stock
667
2000
D
Restricted Stock Units
2015-07-01
2015-07-01
4
A
0
2667
0
A
Common Stock
2667
2667
D
Director Stock Option (right to buy)
57.16
2015-07-01
2015-07-01
4
A
0
16000
0
A
2016-07-01
2025-06-30
Common Stock
16000
16000
D
Acquired pursuant to vesting and release of shares pursuant to an RSU award granted on June 25, 2013.
Acquired pursuant to vesting and release of shares pursuant to an RSU award granted on July 1, 2013.
Acquired pursuant to vesting and release of shares pursuant to an RSU award granted on July 1, 2014.
Each Restricted Stock Unit represents a contingent right to receive one share of Isis common stock, or its equivalent cash value.
Restricted Stock Unit Award granted on June 25, 2013. Restricted Stock Units vest in equal annual installments, the first installment vested on July 1, 2014. Upon vesting, the restricted stock units will be paid out in whole shares of Isis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 1, 2017.
Restricted Stock Unit Award granted on July 1, 2013. Restricted Stock Units vest in equal annual installments, the first installment vested on July 1, 2014. Upon vesting, the restricted stock units will be paid out in whole shares of Isis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 1, 2017.
Restricted Stock Unit Award granted on July 1, 2014. Restricted Stock Units vest in equal annual installments, the first installment vested on July 1, 2015. Upon vesting, the restricted stock units will be paid out in whole shares of Isis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 1, 2018.
Grant of July 1, 2015 to reporting person of Restricted Stock Unit Award under the Isis Pharmacueticals, Inc. Amended and Restated 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on July 1, 2016. Upon vesting, the restricted stock units will be paid out in whole shares of Isis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 1, 2019. The RSU is vested as to 0 shares on July 1, 2015.
Grant of July 1, 2015 to reporting person of stock options under the Isis Pharmacueticals, Inc. Amended & Restated 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on July 1, 2016. The option shall be fully vested and exercisable on July 1, 2019. The stock option was exercisable as to 0 shares on July 1, 2015.
/s/B. Lynne Parshall, attorney-in-fact
2015-07-02